UTHR insider buying and SEC filings, explained
United Therapeutics Corp. · CIK 1082554
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$356K
Planned sales (10b5-1)
$1.4B
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 2, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $596.22 ($5.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Nov 3, 2026, 4:30 PM ET |
| Oct 30, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $600.09 ($5.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Nov 2, 2026, 4:34 PM ET |
| Oct 29, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $594.78 ($5.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 30, 2026, 4:30 PM ET |
| Oct 28, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $585.49 ($5.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 29, 2026, 4:30 PM ET |
| Oct 27, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $587.73 ($5.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 28, 2026, 4:30 PM ET |
| Oct 26, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $588.64 ($5.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 27, 2026, 4:30 PM ET |
| Oct 23, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $582.76 ($5.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 26, 2026, 4:31 PM ET |
| Oct 22, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $583.38 ($5.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 23, 2026, 4:35 PM ET |
| Oct 21, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $560.07 ($5.3M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 22, 2026, 4:36 PM ET |
| Oct 20, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $553.87 ($5.3M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 21, 2026, 4:34 PM ET |
| Oct 19, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $543.32 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 20, 2026, 4:36 PM ET |
| Oct 16, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $534.66 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 19, 2026, 4:33 PM ET |
| Oct 15, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $546.65 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 16, 2026, 4:35 PM ET |
| Oct 15, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $544.30 ($4.5M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Oct 16, 2026, 4:34 PM ET |
| Oct 14, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $539.99 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 15, 2026, 4:34 PM ET |
| Oct 13, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $545.52 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 14, 2026, 4:31 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $550.70 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 13, 2026, 4:31 PM ET |
| Oct 9, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $544.94 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 13, 2026, 4:30 PM ET |
| Oct 8, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $534.31 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 9, 2026, 4:31 PM ET |
| Oct 7, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $548.95 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 8, 2026, 5:28 PM ET |
| Oct 6, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $538.67 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 7, 2026, 4:35 PM ET |
| Oct 5, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $541.64 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 6, 2026, 4:32 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $549.37 ($5.2M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 5, 2026, 4:53 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $576.47 ($5.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Oct 2, 2026, 4:31 PM ET |
| Oct 1, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $564.95 ($4.7M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Oct 1, 2026, 5:30 PM ET |
| Sep 30, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 1,920 shares indirectly (by trust) at about $550.22 ($1.1M), marked as a 10b5-1 plan trade. Holdings by trust down 1% to 324,443 shares. | SEC filing Filed Oct 1, 2026, 5:22 PM ET |
| Sep 30, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 7,580 shares indirectly (by trust) at about $517.97 ($3.9M), marked as a 10b5-1 plan trade. Holdings by trust down 2% to 326,363 shares. | SEC filing Filed Oct 1, 2026, 5:20 PM ET |
| Sep 29, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $477.42 ($4.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 30, 2026 |
| Sep 28, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $480.85 ($4.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $476.17 ($4.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 28, 2026 |
| Sep 24, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $473.55 ($4.5M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 25, 2026 |
| Sep 23, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $491.57 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 24, 2026 |
| Sep 22, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $494.83 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 23, 2026 |
| Sep 21, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $494.55 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 22, 2026 |
| Sep 18, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $494.79 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 21, 2026 |
| Sep 17, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $497.54 ($4.1M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Sep 18, 2026 |
| Sep 17, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $496.06 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 18, 2026 |
| Sep 16, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $501.39 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 15, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $501.59 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 14, 2026 | Sale | Nilda Mesa (Director) sold 228 shares at about $505.87 ($115K). Holdings down 4% to 5,580 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 15, 2026 |
| Sep 14, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $504.12 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 15, 2026 |
| Sep 11, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $500.82 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 14, 2026 |
| Sep 10, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $502.35 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 11, 2026 |
| Sep 9, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $501.84 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 10, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $499.03 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 9, 2026 |
| Sep 4, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $489.20 ($4.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 8, 2026 |
| Sep 3, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $487.54 ($4.6M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 4, 2026 |
| Sep 3, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $482.03 ($4.0M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Sep 3, 2026 |
| Sep 2, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $493.46 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $514.09 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 2, 2026 |
| Aug 31, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $511.08 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Sep 1, 2026 |
| Aug 28, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $517.51 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 31, 2026 |
| Aug 27, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $522.57 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 26, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $517.28 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 27, 2026 |
| Aug 25, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $517.71 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 26, 2026 |
| Aug 24, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $511.97 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $518.39 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 24, 2026 |
| Aug 20, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $523.14 ($4.3M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 20, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $521.02 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $526.96 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 20, 2026 |
| Aug 18, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $515.60 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 17, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $506.59 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 18, 2026 |
| Aug 14, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $498.91 ($4.7M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 17, 2026 |
| Aug 13, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $504.24 ($4.8M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 14, 2026 |
| Aug 12, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $515.03 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 13, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $522.87 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 12, 2026 |
| Aug 10, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $530.11 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $531.38 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 10, 2026 |
| Aug 6, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $525.36 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 7, 2026 |
| Aug 6, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $517.05 ($4.3M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Aug 6, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $518.73 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 6, 2026 |
| Aug 4, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $517.09 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $516.06 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 4, 2026 |
| Jul 31, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $518.96 ($4.9M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Aug 3, 2026 |
| Jul 30, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $524.90 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 31, 2026 |
| Jul 29, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $522.37 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 30, 2026 |
| Jul 28, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $526.73 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 28, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $530.42 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 27, 2026 |
| Jul 24, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $531.74 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 27, 2026 |
| Jul 23, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $528.58 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 24, 2026 |
| Jul 22, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $530.57 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 23, 2026 |
| Jul 21, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $532.24 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 22, 2026 |
| Jul 20, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $531.69 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 21, 2026 |
| Jul 17, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $537.05 ($5.1M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 20, 2026 |
| Jul 16, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares indirectly (by trust) at about $530.91 ($5.0M), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 324,443 shares. | SEC filing Filed Jul 17, 2026 |
| Jul 16, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $533.69 ($4.4M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Jul 16, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares directly and indirectly (by trust) at about $530.35 ($5.0M), marked as a 10b5-1 plan trade. Direct holdings down 4% to 40,513 shares. | SEC filing Filed Jul 16, 2026 |
| Jul 14, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $526.83 ($5.0M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 15, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $536.00 ($5.1M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $544.60 ($5.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 13, 2026 |
| Jul 10, 2026 | Planned (10b5-1) | Jan Malcolm (Director) sold 325 shares at $550.59 ($179K), marked as a 10b5-1 plan trade. Holdings down 42% to 450 shares. | SEC filing Filed Jul 10, 2026 |
| Jul 9, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $551.13 ($5.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 9, 2026 |
| Jul 8, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $553.17 ($5.3M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 9, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $558.87 ($5.3M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 8, 2026 |
| Jul 6, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $548.96 ($5.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 7, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Paul A. Mahon (EVP & General Counsel) sold 8,300 shares at about $552.57 ($4.6M), marked as a 10b5-1 plan trade. Holdings down 16% to 45,172 shares. | SEC filing Filed Jul 2, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $554.61 ($5.3M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 2, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $543.66 ($5.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $541.01 ($5.1M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 29, 2026 | Planned (10b5-1) | Martine A. Rothblatt (CEO and Director) sold 9,500 shares at about $545.80 ($5.2M), marked as a 10b5-1 plan trade. Holdings down 19% to 40,513 shares. | SEC filing Filed Jun 30, 2026 |
Showing the latest 100 transactions.
314 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow UTHR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.